Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 3
1988 1
1989 6
1990 4
1991 2
1992 5
1993 8
1994 16
1995 11
1996 10
1997 7
1998 7
1999 5
2000 2
2001 7
2002 2
2003 8
2004 10
2005 6
2006 5
2007 5
2008 14
2009 9
2010 10
2011 10
2012 14
2013 16
2014 13
2015 17
2016 18
2017 14
2018 13
2019 10
2020 12
2021 6
2022 5
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

287 results

Results by year

Filters applied: . Clear all
Page 1
An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes.
Herold KC, Bundy BN, Long SA, Bluestone JA, DiMeglio LA, Dufort MJ, Gitelman SE, Gottlieb PA, Krischer JP, Linsley PS, Marks JB, Moore W, Moran A, Rodriguez H, Russell WE, Schatz D, Skyler JS, Tsalikian E, Wherrett DK, Ziegler AG, Greenbaum CJ; Type 1 Diabetes TrialNet Study Group. Herold KC, et al. N Engl J Med. 2019 Aug 15;381(7):603-613. doi: 10.1056/NEJMoa1902226. Epub 2019 Jun 9. N Engl J Med. 2019. PMID: 31180194 Free PMC article. Clinical Trial.
Retraction.
Minakawa Y, Peakman M. Minakawa Y, et al. Among authors: peakman m. Clin Exp Immunol. 2008 Dec;154(3):433-4. doi: 10.1111/j.1365-2249.2008.03824.x. Clin Exp Immunol. 2008. PMID: 19058349 Free PMC article. No abstract available.
Tryptophan metabolism promotes immune evasion in human pancreatic β cells.
Rachdi L, Zhou Z, Berthault C, Lourenço C, Fouque A, Domet T, Armanet M, You S, Peakman M, Mallone R, Scharfmann R. Rachdi L, et al. Among authors: peakman m. EBioMedicine. 2023 Sep;95:104740. doi: 10.1016/j.ebiom.2023.104740. Epub 2023 Aug 1. EBioMedicine. 2023. PMID: 37536063 Free PMC article.
Gene expression signature predicts rate of type 1 diabetes progression.
Suomi T, Starskaia I, Kalim UU, Rasool O, Jaakkola MK, Grönroos T, Välikangas T, Brorsson C, Mazzoni G, Bruggraber S, Overbergh L, Dunger D, Peakman M, Chmura P, Brunak S, Schulte AM, Mathieu C, Knip M, Lahesmaa R, Elo LL; INNODIA Consortium. Suomi T, et al. Among authors: peakman m. EBioMedicine. 2023 Jun;92:104625. doi: 10.1016/j.ebiom.2023.104625. Epub 2023 May 22. EBioMedicine. 2023. PMID: 37224769 Free PMC article.
Peptide Immunotherapy for Type 1 Diabetes-Clinical Advances.
Smith EL, Peakman M. Smith EL, et al. Among authors: peakman m. Front Immunol. 2018 Feb 28;9:392. doi: 10.3389/fimmu.2018.00392. eCollection 2018. Front Immunol. 2018. PMID: 29541078 Free PMC article. Review.
The challenge of modulating β-cell autoimmunity in type 1 diabetes.
Atkinson MA, Roep BO, Posgai A, Wheeler DCS, Peakman M. Atkinson MA, et al. Among authors: peakman m. Lancet Diabetes Endocrinol. 2019 Jan;7(1):52-64. doi: 10.1016/S2213-8587(18)30112-8. Epub 2018 Oct 24. Lancet Diabetes Endocrinol. 2019. PMID: 30528099 Free PMC article. Review.
Recent advances. Immunology.
Kemeny M, Peakman M. Kemeny M, et al. Among authors: peakman m. BMJ. 1998 Feb 21;316(7131):600-3. doi: 10.1136/bmj.316.7131.600. BMJ. 1998. PMID: 9518915 Free PMC article. Review. No abstract available.
287 results